Influenza, Human Clinical Trials

220 clinical trials for Influenza, Human across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) — RECRUITING · PHASE1
• Flu Infection at UPHS — RECRUITING
• Clinical Trials of Quadrivalent Influenza Vaccine — RECRUITING · PHASE1
• A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza — RECRUITING · PHASE2
• Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults — RECRUITING · PHASE4
• Covid-19 and Influenza Oral Vaccine Study — RECRUITING · PHASE1
• Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications — RECRUITING · PHASE3
• A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® vaccine in Healthy Volunteers — COMPLETED · PHASE4
• A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine containing the 2013/2014 Formulation of Enzira® vaccine in Healthy Volunteers — COMPLETED · PHASE4
• A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® vaccine in Healthy Volunteers — COMPLETED · PHASE4
• Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years — COMPLETED · PHASE4
• An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection — COMPLETED · PHASE2
• Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP) — NOT_YET_RECRUITING · NA
• Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age — COMPLETED · PHASE2
• A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age — COMPLETED · PHASE3
• A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — COMPLETED · PHASE1
• Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites — COMPLETED · NA
• A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older — COMPLETED · PHASE2
• Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong — COMPLETED · PHASE4
• Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures — COMPLETED · PHASE4
• A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed — COMPLETED · PHASE2
• Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults — COMPLETED · PHASE1
• A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above — ACTIVE_NOT_RECRUITING · PHASE2
• Vaccine Pandemic Preparedness Through Airway Immunology Characterization — ACTIVE_NOT_RECRUITING · PHASE1
• A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza — COMPLETED · PHASE1
• Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD — NOT_YET_RECRUITING
• A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults — COMPLETED · PHASE1
• A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults — COMPLETED · PHASE2
• Vaccination Nudges From Pharmacists — ACTIVE_NOT_RECRUITING · NA
• A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults — COMPLETED · PHASE1
• A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older — OTHER · PHASE2
• Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults — COMPLETED · PHASE1
• Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS — NOT_YET_RECRUITING · PHASE1
• A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults — COMPLETED · PHASE2
• Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children . — COMPLETED · PHASE3
• An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outcomes of treatment with intravenous (IV) zanamivir in neonates and infants under 6 months of age with confirmed complicated influenza infection. — OTHER · PHASE2
• A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older. — OTHER · PHASE2
• Herd Immunity and Influenza Vaccine Uptake — COMPLETED · NA
• Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults — COMPLETED · PHASE1
• A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People — COMPLETED · PHASE1
• A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults — COMPLETED · PHASE1
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza — COMPLETED · PHASE2
• Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV) — COMPLETED · PHASE1
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — COMPLETED · PHASE3
• The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older — COMPLETED · PHASE3
• Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection — ACTIVE_NOT_RECRUITING
• A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India — COMPLETED · PHASE4
• Efficacy Study With QIVc in Pediatric Subjects — COMPLETED · PHASE3
• Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine — COMPLETED · PHASE3
• Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine — NOT_YET_RECRUITING · PHASE3

Refine this search